210 related articles for article (PubMed ID: 29989199)
21. Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
Fanale MA; Younes A
Drugs; 2007; 67(3):333-50. PubMed ID: 17335294
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study.
Coiffier B; Mounier N; Bologna S; Fermé C; Tilly H; Sonet A; Christian B; Casasnovas O; Jourdan E; Belhadj K; Herbrecht R;
J Clin Oncol; 2003 Dec; 21(23):4402-6. PubMed ID: 14581437
[TBL] [Abstract][Full Text] [Related]
23. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
24. [Primary intramuscular non-Hodgkin's lymphoma in young subjects: about a case and review of the literature].
Majdoul S; Omari N; Allali Y; Ghabri R; Benchakroun N; Fadili M; Tawfiq N; Jouhadi H; Sahraoui S; Nechad M; Benider A
Pan Afr Med J; 2016; 25():223. PubMed ID: 28293339
[TBL] [Abstract][Full Text] [Related]
25. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index.
Janssen-Heijnen ML; van Spronsen DJ; Lemmens VE; Houterman S; Verheij KD; Coebergh JW
Br J Haematol; 2005 Jun; 129(5):597-606. PubMed ID: 15916681
[TBL] [Abstract][Full Text] [Related]
26. Struggling with paradoxes: the process of spiritual development in women with cancer.
Halstead MT; Hull M
Oncol Nurs Forum; 2001; 28(10):1534-44. PubMed ID: 11759301
[TBL] [Abstract][Full Text] [Related]
27. HIV-associated non-Hodgkin's lymphoma: experience from a regional cancer center.
Sharma A; Bajpai J; Raina V; Mohanti BK
Indian J Cancer; 2010; 47(1):35-9. PubMed ID: 20071788
[TBL] [Abstract][Full Text] [Related]
28. I'm still me, I'm still a person: war metaphor use and meaning making in women with metastatic breast cancer.
Hulse SB; Balogun Z; Rosenzweig MQ; Marsland AL; Palmer VM
Support Care Cancer; 2024 Jan; 32(2):108. PubMed ID: 38231307
[TBL] [Abstract][Full Text] [Related]
29. Rituximab monotherapy is effective in patients with poor risk refractory aggressive non-Hodgkin's lymphoma.
Rothe A; Schulz H; Elter T; Engert A; Reiser M
Haematologica; 2004 Jul; 89(7):875-6. PubMed ID: 15257947
[TBL] [Abstract][Full Text] [Related]
30. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
Torizuka T; Nakamura F; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Kobayashi M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
[TBL] [Abstract][Full Text] [Related]
31. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
32. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
33. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
[TBL] [Abstract][Full Text] [Related]
34. Dancing around infertility: the use of metaphors in a complex medical situation.
Palmer-Wackerly AL; Krieger JL
Health Commun; 2015; 30(6):612-23. PubMed ID: 25061825
[TBL] [Abstract][Full Text] [Related]
35. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy.
Lee JJ; Nam CE; Cho SH; Park KS; Chung IJ; Kim HJ
Ann Hematol; 2003 Aug; 82(8):492-495. PubMed ID: 12910376
[TBL] [Abstract][Full Text] [Related]
36. Non-Hodgkin's lymphoma in the elderly: a guide to drug treatment.
Niitsu N
Drugs Aging; 1999 Jun; 14(6):447-57. PubMed ID: 10408743
[TBL] [Abstract][Full Text] [Related]
37. Experiences prior to diagnosis of non-Hodgkin lymphoma: a phenomenological study.
Wall C; Glenn S; Poole H
J Adv Nurs; 2011 Nov; 67(11):2363-72. PubMed ID: 21517940
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of GDP regimen (gemcitabine, dexamethasone, and cisplatin) on relapsed or refractory aggressive non-Hodgkin's Lymphoma: a report of 24 cases].
Fan Y; Huang ZY; Luo LH; Yu HF
Ai Zheng; 2008 Nov; 27(11):1222-5. PubMed ID: 19000458
[TBL] [Abstract][Full Text] [Related]
39. Computed tomography, magnetic resonance imaging and positron emission tomography in non-Hodgkin's lymphoma.
Rodriguez M
Acta Radiol Suppl; 1998; 417():1-36. PubMed ID: 9645167
[TBL] [Abstract][Full Text] [Related]
40. The relationship between learned resourcefulness and cancer-related fatigue in patients with non-Hodgkin lymphoma.
Menshadi N; Bar-Tal Y; Barnoy S
Oncol Nurs Forum; 2013 Mar; 40(2):133-8. PubMed ID: 23448738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
